This inventor holds 1 USPTO granted patent. Top assignee: University of Iowa Research Foundation. Active years: 1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998
Title: Minoru Matsui: Innovator in Immuno-Regulatory Proteins
Introduction
Minoru Matsui is a distinguished inventor based in Kyoto, Japan. He is known for his significant contributions to the field of immunology, particularly through his innovative work on immuno-regulatory proteins. His research has the potential to impact the treatment of various IgE mediated diseases.
Latest Patents
Matsui holds a patent for "DNA sequences for soluble form of CD23." This invention discloses the isolation and purification of gene sequences that code for a soluble form of the traditionally membrane-bound immuno-regulatory protein, CD23. This protein plays a crucial role in regulating the amount of IgE present in the blood. Upon cloning and amplification, the procedures developed may be utilized in the treatment of IgE mediated diseases.
Career Highlights
Minoru Matsui is affiliated with the University of Iowa Research Foundation, where he continues to advance his research in immunology. His work has garnered attention for its potential applications in medical treatments and therapies.
Collaborations
Matsui has collaborated with notable colleagues, including Richard G. Lynch and Rafael M. Nunez. These partnerships have contributed to the depth and breadth of his research endeavors.
Conclusion
Minoru Matsui's innovative work in the field of immunology, particularly with his patent on CD23, showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of IgE mediated diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile